ROGAINE Drug Patent Profile
✉ Email this page to a colleague
When do Rogaine patents expire, and what generic alternatives are available?
Rogaine is a drug marketed by Kenvue Brands and is included in two NDAs.
The generic ingredient in ROGAINE is minoxidil. There are eight drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rogaine
A generic version of ROGAINE was approved as minoxidil by WATSON LABS on March 3rd, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ROGAINE?
- What are the global sales for ROGAINE?
- What is Average Wholesale Price for ROGAINE?
Summary for ROGAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | ROGAINE at DailyMed |
US Patents and Regulatory Information for ROGAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kenvue Brands | ROGAINE (FOR MEN) | minoxidil | SOLUTION;TOPICAL | 019501-002 | Feb 9, 1996 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kenvue Brands | ROGAINE (FOR WOMEN) | minoxidil | SOLUTION;TOPICAL | 019501-003 | Feb 9, 1996 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kenvue Brands | ROGAINE EXTRA STRENGTH (FOR MEN) | minoxidil | SOLUTION;TOPICAL | 020834-001 | Nov 14, 1997 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
